2000 Participants Needed

Data Collection for Breast Cancer

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to gather samples and information to better understand the development and progression of recurrent or metastatic breast cancer, including male breast cancer. Participants will provide blood and tissue samples and allow researchers to review their medical records. It is ideal for individuals diagnosed with invasive breast cancer or male breast cancer. The study does not involve new treatments but focuses on collecting valuable data to improve future therapies. As an unphased trial, it offers participants the chance to contribute to crucial research that may enhance future cancer treatments.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with your doctor or the trial coordinators.

Why are researchers excited about this trial?

Researchers are excited about this trial because it focuses on collecting specimens and clinical data from patients with recurrent or metastatic breast cancer, including male breast cancer. Unlike traditional treatments that directly target the cancer cells, this trial aims to gather comprehensive biological and clinical information, which could lead to new insights into the disease. By analyzing blood samples, tissue samples, and medical records, scientists hope to uncover patterns and biomarkers that could pave the way for more personalized and effective treatments in the future. This observational approach is unique in that it seeks to enhance our understanding of the disease's progression and response to existing therapies, rather than testing a new drug or treatment method.

Who Is on the Research Team?

FJ

Fergus J. Couch, Ph.D.

Principal Investigator

Mayo Clinic in Rochester

Are You a Good Fit for This Trial?

Inclusion Criteria

Women must have a confirmed diagnosis of invasive breast cancer through a tissue sample.
Men participating in the study must have breast cancer confirmed by a biopsy.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Specimen Collection

Patients undergo blood sample collection and tumor biopsy

Baseline
1 visit (in-person)

Data Review

Medical records are reviewed to collect clinical data

Ongoing

Follow-up

Participants are monitored for changes in tumor cells and response to therapies

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Non-Interventional Study

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: ObservationalExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+